EPA, Justice Dept. Seek Civil Penalties In East Palestine Wreck
FDA Authorizes COVID Bivalent Booster for More Young Children
March 15, 2023
by Dan McCue
WASHINGTON — The Food and Drug Administration has amended its emergency use authorization of the Pfizer-BioNTech COVID-19 Bivalent vaccine, authorizing its use as a single booster dose for children 6 months through 4 years who’ve completed their primary vaccinations with the monovalent version.
The agency said in a press release Tuesday that the booster should only be administered two months or more after the individual child has completed a primary vaccination with three doses of the monovalent (single strain) Pfizer-BioNTech COVID-19 Vaccine.
“Today’s authorization provides parents and caregivers of children 6 months through 4 years of age who received the three-dose primary series with the monovalent Pfizer-BioNTech COVID-19 Vaccine an opportunity to update their children’s protection by receiving a booster dose with the Pfizer-BioNTech COVID-19 Vaccine, Bivalent,” said Peter Marks, director of the FDA’s Center for Biologics Evaluation and Research, in a written statement.
“Currently available data show that vaccination remains the best defense against severe disease, hospitalization and death caused by COVID-19 across all age groups, and we encourage all eligible individuals to make sure that their vaccinations are up to date with a bivalent COVID-19 vaccine,” he said.
Children 6 months through 4 years of age who received their first two doses with monovalent Pfizer-BioNTech COVID-19 Vaccine have been eligible to complete their three-dose primary series with the Pfizer-BioNTech COVID-19 Bivalent vaccine since December 2022.
The agency said children in this age group are not eligible for a booster dose of a bivalent vaccine at this time and are expected to have protection against the most serious COVID-19 outcomes.
It goes on to state that the Pfizer-BioNTech COVID-19 Bivalent vaccine includes an mRNA component corresponding to the original virus strain to provide an immune response that is broadly protective against COVID-19 and an mRNA component corresponding to the omicron variants BA.4 and BA.5 to provide better protection against COVID-19 caused by the omicron variant.
Dan can be reached at [email protected] and @DanMcCue
A+
a-
In The News
Health
Voting
Health
March 31, 2023
by Dan McCue
EPA, Justice Dept. Seek Civil Penalties In East Palestine Wreck
WASHINGTON — The Environmental Protection Agency, in coordination with the U.S. Justice Department, is seeking potentially millions of dollars in... Read More
WASHINGTON — The Environmental Protection Agency, in coordination with the U.S. Justice Department, is seeking potentially millions of dollars in civil fines from the Norfolk Southern Railway Co. in connection to the Feb. 3 derailment of a train carrying hazardous materials near East Palestine, Ohio. In... Read More
March 31, 2023
by Kate Michael
Analysts Blame Farm Runoff for Toxic Algae Blooms
WASHINGTON — Americans starting to think about spring and summer vacations as the weather warms may find their favorite water... Read More
WASHINGTON — Americans starting to think about spring and summer vacations as the weather warms may find their favorite water destinations unsafe for swimming. Thick layers of cyanobacteria — commonly known as blue-green algae — have closed popular local lakes in recent years, and Florida has... Read More
March 30, 2023
by Transgender Visibility Saves Lives in the Clinic, Too
Transgender Visibility Saves Lives in the Clinic, Too
The overwhelming evidence and consensus among global health organizations is that gender-affirming care saves lives. Yet many transgender, nonbinary and... Read More
The overwhelming evidence and consensus among global health organizations is that gender-affirming care saves lives. Yet many transgender, nonbinary and gender non-conforming people lack access to the care they need. Some must wait up to a year to talk to a medical professional about gender-affirming care.... Read More
March 29, 2023
by Dan McCue
Increased Telehealth Use Reduced Overdose Risk During Pandemic
WASHINGTON — An increased reliance on telehealth services and medications for opioid use disorder by Medicare beneficiaries significantly reduced their... Read More
WASHINGTON — An increased reliance on telehealth services and medications for opioid use disorder by Medicare beneficiaries significantly reduced their risk for fatal overdoses during the COVID-19 pandemic, the National Center for Injury Prevention and Control reported on Wednesday. Published in JAMA Psychiatry, the study is... Read More
Fundraising Over Solutions: Women’s Health and a Missed Opportunity Post-Dobbs
In June 2022 the U.S. Supreme Court issued a decision that provided the sought after political fodder to catapult fundraising... Read More
In June 2022 the U.S. Supreme Court issued a decision that provided the sought after political fodder to catapult fundraising efforts heading into the 2022 midterm election cycle. In the June opinion, the court overruled two cases from 1973 and 1992, and returned the matter of... Read More
March 29, 2023
by Dan McCue
Budzinski Joins Overdose, Addiction Working Groups
WASHINGTON — Rep. Nikki Budzinski, D-Ill., has joined the Bipartisan Fentanyl Prevention Caucus and the Bipartisan Mental Health and Substance... Read More
WASHINGTON — Rep. Nikki Budzinski, D-Ill., has joined the Bipartisan Fentanyl Prevention Caucus and the Bipartisan Mental Health and Substance Use Disorder Task Force where, she says, she will work across the aisle on solutions to the ongoing addiction crisis. “Every day, too many of our... Read More
News From The Well
